Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 203 entries
View as:

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00003943 Org: User:
Start: 09/30/98 End: 02/28/03 Due: 02/28/04

PHL Treatment in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05365893 Org: User:
Start: 10/20/21 End: 12/31/26 Due: 12/31/27

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03786692 Org: User:
Start: 09/04/19 End: 01/31/28 Due: 01/31/29

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05360732 Org: User:
Start: 04/22/22 End: 09/01/25 Due: 09/01/26

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02132884 Org: User:
Start: 03/31/15 End: 08/31/16 Due: 08/31/17

Comparative Effectiveness of CTC & OC

Phase: N/A Priority: Normal
NCT ID: NCT02143115 Org: User:
Start: 08/31/11 End: 06/30/16 Due: 06/30/17

Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures

Phase: N/A Priority: Normal
NCT ID: NCT04037072 Org: User:
Start: 04/03/20 End: 12/15/22 Due: 12/15/23

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05263050 Org: User:
Start: 01/21/22 End: 02/28/27 Due: 02/28/28

A Biobehavioral Model of Diabetes Risk in Chinese Immigrants

Phase: N/A Priority: Normal
NCT ID: NCT02449213 Org: User:
Start: 03/11/16 End: 05/05/21 Due: 05/05/22

Genomic Risk in Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06436846 Org: User:
Start: 03/07/22 End: 08/01/27 Due: 08/01/28

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00604409 Org: User:
Start: 04/30/06 End: 01/31/15 Due: 01/31/16

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02614859 Org: User:
Start: 12/01/15 End: 01/24/20 Due: 01/24/21

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01212822 Org: User:
Start: 04/27/11 End: 01/03/18 Due: 01/03/19

nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy

Phase: N/A Priority: Normal
NCT ID: NCT04441749 Org: User:
Start: 06/29/20 End: 12/31/23 Due: 12/31/24

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01183559 Org: User:
Start: 08/07/08 End: 08/31/11 Due: 08/31/12

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT00321100 Org: User:
Start: 04/12/06 End: 12/18/13 Due: 12/18/14

Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02092714 Org: User:
Start: 10/16/13 End: 11/16/20 Due: 11/16/21

Smoking Cessation for Low-Income Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT02211430 Org: User:
Start: 10/31/02 End: 03/31/07 Due: 03/31/08

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00350025 Org: User:
Start: 08/31/06 End: 09/30/12 Due: 09/30/13

Coping Together After Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03930797 Org: User:
Start: 05/24/19 End: 04/14/23 Due: 04/14/24

Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02721147 Org: User:
Start: 10/27/15 End: 09/29/17 Due: 09/29/18

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00041353 Org: User:
Start: - End: 09/30/02 Due: 09/30/03

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Phase: N/A Priority: Normal
NCT ID: NCT03311620 Org: User:
Start: 05/15/18 End: 06/08/20 Due: 06/08/21

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01637194 Org: User:
Start: 11/30/08 End: 07/31/11 Due: 07/31/12

Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03302247 Org: User:
Start: 01/15/18 End: 07/12/19 Due: 07/12/20